Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the MyChoice ® CDx ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It's the latest example of medical tests that contribute to health ...

Myriad Genetics received approval for a diagnostic test aimed at identifying advanced ovarian cancer patients eligible for treatment with Zejula from the Food and Drug Administration. The diagnostic ...

Discover the groundbreaking Elecsys® AMH Plus blood test by Redcliffe Labs and Roche Diagnostics India that offers an easier, less invasive way to diagnose Polycystic Ovary Syndrome (PCOS), ensuring ...

Premenopausal women would benefit from a significantly more accurate diagnostic pathway for ovarian cancer, as a new study finds that an advanced ultrasound test, IOTA ADNEX, identified 9 out of 10 ...

Rapid genetic test for IVF identifies FSHR variant in 60 minutes, guiding IVF hormone selection and improving in vitro fertilization success.

A potential world-changing test developed in Queensland is set to be trialled among 1500 women in the hopes it can be come a ...

As an eager tester of new therapies to reduce her biological age, or how fast she is aging internally, Barnes-Lentz thrives on collecting more data about her health. It’s especially important for her ...

Ovarian cancer is treatable is detected early, but 70% of cases aren’t diagnosed until it’s too late. A promising blood test may change that. Each year, about 20,000 women are diagnosed with ovarian ...